BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24621471)

  • 1. Prevalence and control of high blood pressure in primary care: results from the German Metabolic and Cardiovascular Risk Study (GEMCAS).
    Balijepalli C; Bramlage P; Lösch C; Zemmrich C; Humphries KH; Moebus S
    Hypertens Res; 2014 Jun; 37(6):580-4. PubMed ID: 24621471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of metabolic risk factors with uncontrolled hypertension: comparison of the several definitions of metabolic syndrome.
    Cortez-Dias N; Martins SR; Belo A; Fiuza M;
    J Hypertens; 2013 Oct; 31(10):1991-7. PubMed ID: 23811998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control and management of very elderly patients with hypertension in primary care settings in Spain.
    Rodriguez-Roca GC; Llisterri JL; Prieto-Diaz MA; Alonso-Moreno FJ; Escobar-Cervantes C; Pallares-Carratala V; Valls-Roca F; Barrios V; Banegas JR; Alsina DS
    Hypertens Res; 2014 Feb; 37(2):166-71. PubMed ID: 24089262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey.
    Van der Niepen P; Giot C; van de Borne P
    J Hypertens; 2008 Oct; 26(10):2057-63. PubMed ID: 18806631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension.
    Uzu T; Kimura G; Yamauchi A; Kanasaki M; Isshiki K; Araki S; Sugiomoto T; Nishio Y; Maegawa H; Koya D; Haneda M; Kashiwagi A
    J Hypertens; 2006 Aug; 24(8):1627-32. PubMed ID: 16877966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension management in England: a serial cross-sectional study from 1994 to 2011.
    Falaschetti E; Mindell J; Knott C; Poulter N
    Lancet; 2014 May; 383(9932):1912-9. PubMed ID: 24881995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adjusted versus overall blood pressure control rate for identifying the need for intensified cardiovascular risk reduction: lessons from a cross-sectional study.
    In der Schmitten J; Wegscheider K; Abholz HH; Mortsiefer A
    Eur J Prev Cardiol; 2013 Dec; 20(6):972-9. PubMed ID: 23253744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension.
    Gee ME; Bienek A; McAlister FA; Robitaille C; Joffres M; Tremblay MS; Johansen H; Campbell NR
    Can J Cardiol; 2012 May; 28(3):375-82. PubMed ID: 22402028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
    Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
    Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.
    Joffres MR; Hamet P; Rabkin SW; Gelskey D; Hogan K; Fodor G
    CMAJ; 1992 Jun; 146(11):1997-2005. PubMed ID: 1596849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.
    Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.